Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 23;15(8):e43977.
doi: 10.7759/cureus.43977. eCollection 2023 Aug.

Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors

Affiliations
Review

Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors

Tamam Mohamad et al. Cureus. .

Abstract

The field of cardiovascular medicine is undergoing a transformative shift towards personalized medicinal therapy, particularly in the context of post stent implantation. This narrative review explores the significance, challenges, and future directions of individualized treatment strategies for patients with coronary stents. The review highlights the pivotal role of personalized approaches in optimizing treatment efficacy and minimizing adverse events. Real-world clinical studies and trials underscore the importance of tailoring antiplatelet therapy based on platelet function testing, genetic testing, and risk scoring. These studies reveal that personalized medicinal treatment improves clinical outcomes by balancing preventing thrombotic events and mitigating bleeding risks. Challenges, including cost, test availability, patient adherence, and ethical considerations, are discussed in depth, shedding light on the complexities of implementing personalized approaches. Technological advancements, including omics data integration, artificial intelligence, and big data analytics, shape the future of personalized medicinal therapy. These tools enable precise pharmacogenomic selection of medications and the development of integrated risk-scoring systems. Patient engagement and education are also central, with empowered patients and remote monitoring contributing to collaborative decision-making. In conclusion, the narrative review underscores that personalized medicinal therapy post stent implantation holds immense promise for revolutionizing cardiovascular care. By embracing a comprehensive approach that considers genetics, clinical factors, and patient preferences, healthcare providers can optimize treatment outcomes and improve patient quality of life. The evolving landscape of personalized medicine offers a glimpse into a future where tailored treatment strategies become the cornerstone of precision cardiovascular care.

Keywords: bare metal stents; cardiovascular medicine; coronary stent implantation; drug-eluting stents; heart; implantation; stent; tailored treatment strategies; technological advancement; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Range of factors correlated with in-stent thrombosis
Credit: Authors

Similar articles

Cited by

References

    1. Development of biodegradable polymeric stents for the treatment of cardiovascular diseases. Shen Y, Yu X, Cui J, et al. Biomolecules. 2022;12:1245. - PMC - PubMed
    1. Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: a meta-analysis. Wu JJ, Way JA, Kritharides L, Brieger D. Ann Med Surg (Lond) 2019;38:13–21. - PMC - PubMed
    1. A review of the ultrathin orsiro biodegradable polymer drug-eluting stent in the treatment of coronary artery disease. Wu JJ, Way JA, Brieger D. Heart Int. 2019;13:17–24. - PMC - PubMed
    1. Durable polymer versus biodegradable polymer drug-eluting stents after percutaneous coronary intervention in patients with acute coronary syndrome: the HOST-REDUCE-POLYTECH-ACS trial. Kim HS, Kang J, Hwang D, et al. Circulation. 2021;143:1081–1091. - PubMed
    1. Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis. Andersen BK, Ding D, Mogensen LJH, Tu S, Holm NR, Westra J, Wijns W. Eur Heart J Qual Care Clin Outcomes. 2022;2:99–108. - PubMed

LinkOut - more resources